Capital Flow Monitor · Sponsors · CIK 2110866
Atlas Oncology Holdings Inc.
1316 ADAMS STREET, NASHVILLE, TN, 37208 · 615-864-0524
Other · Corporation· inc. DELAWARE true 2023
Fit score
—
Offering
$23.0M
Sold
$23.0M
% sold
100.0%
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-02-25 | D ·current | 506(b) | $23.0M | $23.0M | 100.0% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Kate Barnard Roberts — Executive Officer / Promoter, Nashville, TN
-
Ian Chiang — Director, Nashville, TN
2 other raises
- knownwell, inc. $26.1M of $26.1M · 100.0%
- 2GHealth Inc. $10.4M of $10.4M · 100.0%
- Tara Sullivan — Director, Nashville, TN
-
David Glaccum — Executive Officer / Director / Promoter, Nashville, TN
1 other raise
- Rubicon Founders Ivy Fund, LP $0 of —
- Matt Kim — Director / Promoter, Nashville, TN
- Dave Fielding — Director / Promoter, Nashville, TN
-
Todd Nice — Executive Officer / Promoter, Nashville, TN
2 other raises
- Rubicon Founders Ivy Fund, LP $0 of —
- Rubicon Fund II LP $1.12B of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.